Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 14
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Implementation of measures to reduce vasovagal reactions: Donor participation and results | Goldman M, Uzicanin S, Marquis-Boyle L, O'Brien SF | 2021 | Transfusion | View Implementation of measures to reduce vasovagal reactions: Donor participation and results | Health care providers | Clinical research |
Combined preoperative plasma exchange and red blood cell exchange transfusion in a renal transplant patient with protein S deficiency and hemoglobin SC disease | Cook O, Cervi A, Laureano M, Gangji AS, Verhovsek M | 2021 | Transfus Apher Sci | View Combined preoperative plasma exchange and red blood cell exchange transfusion in a renal transplant patient with protein S deficiency and hemoglobin SC disease | Researchers | Clinical research |
Concentré de recherche: Suggestion concernant le mécanisme en jeu dans la thrombocytopénie thrombotique induite par le vaccin | Batarfi K | 2021 | Blood.ca website | View Concentré de recherche: Suggestion concernant le mécanisme en jeu dans la thrombocytopénie thrombotique induite par le vaccin | Researchers | Clinical research |
Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopoïétiques de sang de cordon ombilical | Stewart T | 2021 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopoïétiques de sang de cordon ombilical | Health care providers | Benchmarking and standard setting |
Improving Medical Education in Hematology and Transfusion Medicine in Canada: Standards and Limitations | Laureano M, Mithoowani S, Tseng E, Zeller M | 2021 | Adv Med Educ Pract | View Improving Medical Education in Hematology and Transfusion Medicine in Canada: Standards and Limitations | Health care providers | Benchmarking and standard setting |
Chapter 16: Preoperative autologous donation | Foster T, Yan M | 2021 | Clinical Guide to Transfusion | View Chapter 16: Preoperative autologous donation | Health care providers | Benchmarking and standard setting |
Meta-Analysis of Risk of Vaccine-Induced Immune Thrombotic Thrombocytopenia Following ChAdOx1-S Recombinant Vaccine | Chan BT, Bobos P, Odutayo A, Pai M | 2021 | medRxiv | View Meta-Analysis of Risk of Vaccine-Induced Immune Thrombotic Thrombocytopenia Following ChAdOx1-S Recombinant Vaccine | Researchers | Clinical research |
The Effect of Sex-Mismatched Red Blood Cell Transfusion on Endothelial Cell Activation in Critically Ill Patients | Alshalani A, van Manen L, Boshuizen M, van Bruggen R, Acker JP, Juffermans NP | 2021 | Transfus Med Hemotherapy | View The Effect of Sex-Mismatched Red Blood Cell Transfusion on Endothelial Cell Activation in Critically Ill Patients | Researchers | Clinical research |
Could antigen loss be a potential mechanism to explain antibody-mediated immune suppression? | Cruz-Leal Y, Lazarus AH | 2021 | Transfusion | View Could antigen loss be a potential mechanism to explain antibody-mediated immune suppression? | Researchers | Basic research |
Industry, experts and the role of the ‘invisible college’ in the dissemination of non-invasive prenatal testing in the US | Holloway K, Miller FA, Simms N | 2021 | Soc Sci Med | View Industry, experts and the role of the ‘invisible college’ in the dissemination of non-invasive prenatal testing in the US | Researchers | Ethical, legal and social implications research |
Non-invasive monitoring of red blood cells during cold storage using handheld Raman spectroscopy | Vardaki MZ, Schulze HG, Serrano K, Blades MW, Devine DV, Turner RFB | 2021 | Transfusion | View Non-invasive monitoring of red blood cells during cold storage using handheld Raman spectroscopy | Researchers | New or improved product or process |
Lessons from vaccine-induced immune thrombotic thrombocytopenia | Kelton JG, Arnold DM, Nazy I | 2021 | Nat Rev Immunol | View Lessons from vaccine-induced immune thrombotic thrombocytopenia | Researchers | Clinical research |
Chapitre 6: Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Drews S, Khandelwal A, Goldman M, Devine D | 2021 | Guide de la pratique transfusionnelle | View Chapitre 6: Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Plasma components | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
A decision integration strategy for short-term demand forecasting and ordering for red blood cell components | Li N, Chiang F, Down DG, Heddle NM | 2021 | Oper Res Health Care | View A decision integration strategy for short-term demand forecasting and ordering for red blood cell components | Health care providers | New or improved product or process |
Potentially clinically significant anti-Dib identified by monocyte monolayer assay before transfusion | Branch DR, Holton MB, Ison T, Cote J, Dube C, Lau W | 2021 | Transfusion | View Potentially clinically significant anti-Dib identified by monocyte monolayer assay before transfusion | Researchers | Basic research |
Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT? | Warkentin TE, Smythe MA, Ali MA, Aslam N, Sheppard JI, Smith JW, Moore JC, Arnold DM, Nazy I | 2021 | Am J Hematol | View Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT? | Researchers | Clinical research |
Adverse reactions reporting | Yan M | 2021 | Blood.ca website | View Adverse reactions reporting | Health care providers | Benchmarking and standard setting |
Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes | Sun H, Yang M, Poon M-C, Lee A, Robinson KS, Sholzberg M, Wu J, Iorio A, Blanchette V, Carcao M, Klaassen RJ, Jackson S | 2021 | Haemophilia | View Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes | Researchers | Clinical research |
Challenging the 30-min rule for thawed plasma | Ramirez-Arcos S, Howell A, Bearne J, Bhakta V, Bower L, Cardigan R, Girard M, Kou Y, McDonald C, Nolin M-È, Sawicka D, Sheffield W | 2021 | Vox Sang | View Challenging the 30-min rule for thawed plasma | Researchers | Benchmarking and standard setting |
What constitutes the most cautious approach for a pregnant person with weak D type 4.0? | Lieberman L, Flegel W, Bodnar M, Clarke G, Hannon J | 2021 | CMAJ Open | View What constitutes the most cautious approach for a pregnant person with weak D type 4.0? | Health care providers | Benchmarking and standard setting |
How do I think about blood donor eligibility criteria for medical conditions? | Goldman M | 2021 | Transfusion | View How do I think about blood donor eligibility criteria for medical conditions? | Researchers | Benchmarking and standard setting |
ResearchUnit: A proposed mechanism for vaccine-induced thrombotic thrombocytopenia | Batarfi K | 2021 | Blood.ca website | View ResearchUnit: A proposed mechanism for vaccine-induced thrombotic thrombocytopenia | Researchers | Clinical research |
Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology | Bhalla A, Mukherjee M, Radford K, Nazy I, Kjarsgaard M, Bowdish DME, Nair P | 2021 | Allergy | View Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology | Health care providers | Basic research |
Quality of evidence-based guidelines for platelet transfusion and use: A systematic review | Al-Riyami AZ, Jug R, La Rocca U, Keshavarz H, Landry D, Shehata N, Stanworth SJ, Nahirniak S | 2021 | Transfusion | View Quality of evidence-based guidelines for platelet transfusion and use: A systematic review | Researchers | Benchmarking and standard setting |
Themed issue – focusing on donor assessment, motivation and vigilance | O’Brien SF, Ullum H, Seed CR | 2021 | Vox Sang | View Themed issue – focusing on donor assessment, motivation and vigilance | Researchers | New or improved product or process |
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood | Stewart T | 2021 | Blood.ca website | View Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood | Health care providers | Benchmarking and standard setting |
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B | Olasupo OO, Lowe MS, Krishan A, Collins P, Iorio A, Matino D | 2021 | Cochrane Database Syst Rev | View Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B | Health care providers | Clinical research |
ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group | Goel R, Bloch EM, Pirenne F, Al-Riyami AZ, Crowe E, Dau L, Land K, Townsend M, Jecko T, Rahimi-Levene N, Patidar G, Josephson CD, Arora S, Vermeulen M, Vrielink H, Montemayor C, Oreh A, Hindawi S, van den Berg K, Serrano K, So – Osman C, Wood E, Devine DV, Spitalnik SL, the ISBT COVID-19 Working Group | 2021 | Vox Sang | View ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group | Researchers | Clinical research |
Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Hill-Strathy M, Pinkerton PH, Thompson TA, Wendt A, Collins A, Cohen R, WO BC, Cameron T, Lin Y, Lau W, Lieberman L, Callum J | 2021 | Transfusion | View Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Health care providers | Clinical research |
Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Hadjesfandiari N, Levin E, Serrano K, Yi Q-L, Devine DV | 2021 | Transfusion | View Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Health care providers | Benchmarking and standard setting |
DNA Mediated Blood Coagulation: Extracellular DNA Accelerates Fibrinogen Polymerization By Thrombin Independent of Contact Pathway | Vappala S, Straus S, Pryzdial EL, Conway E, Kizhakkedathu J | 2021 | Blood | View DNA Mediated Blood Coagulation: Extracellular DNA Accelerates Fibrinogen Polymerization By Thrombin Independent of Contact Pathway | Researchers | Basic research |
Reconstituted cryopreserved platelets synthesize proteins during short-term storage and packaging a defined subset into microvesicles | Schubert P, Johnson L, Culibrk B, Chen Z, Tan S, Marks DC, Devine DV | 2021 | Transfusion | View Reconstituted cryopreserved platelets synthesize proteins during short-term storage and packaging a defined subset into microvesicles | Researchers | New or improved product or process |
Major clinical trial finds convalescent plasma does not help patients with COVID-19 | Modi D | 2021 | Ontario Regional Blood Coordinating Network December 2021 Newsletter | View Major clinical trial finds convalescent plasma does not help patients with COVID-19 | Health care providers | Clinical research |
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval | Grunau B, Asamoah-Boaheng M, Lavoie PM, Karim ME, Kirkham TL, Demers PA, Barakauskas V, Marquez AC, Jassem AN, O'Brien SF, Drews SJ, Haig S, Cheskes S, Goldfarb DM | 2021 | Clin Infect Dis | View A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval | Researchers | Clinical research |
Chapter 6: Donor selection, donor testing and pathogen reduction | Drews S, Khandelwal A, Goldman M, Devine D | 2021 | Clinical Guide to Transfusion | View Chapter 6: Donor selection, donor testing and pathogen reduction | Health care providers | Benchmarking and standard setting |
Estimating the impact on the inventory of implementing pathogen-reduced platelets in Canada | Blake JT, McTaggart K, Couture C | 2021 | Transfusion | View Estimating the impact on the inventory of implementing pathogen-reduced platelets in Canada | Blood operators | Benchmarking and standard setting |
Circular of information for the use of human blood components: Platelets | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
FcgammaRI and FcgammaRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia | Norris PAA, Segel GB, Burack WR, Sachs UJ, Lissenberg-Thunnissen SN, Vidarsson G, Bayat B, Cserti-Gazdewich CM, Callum J, Lin Y, Branch D, Kapur R, Semple JW, Lazarus AH | 2021 | Haematologica | View FcgammaRI and FcgammaRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia | Researchers | Basic research |
Pragmatic, double-blind, randomised trial evaluating the impact of red blood cell donor sex on recipient mortality in an academic hospital population: the innovative Trial Assessing Donor Sex (iTADS) protocol | Fergusson DA, Chassé M, Tinmouth A, Acker JP, English S, Forster AJ, Hawken S, Shehata N, Thavorn K, Wilson K, Tuttle A, Perelman I, Cober N, Maddison H, Tokessy M | 2021 | BMJ Open | View Pragmatic, double-blind, randomised trial evaluating the impact of red blood cell donor sex on recipient mortality in an academic hospital population: the innovative Trial Assessing Donor Sex (iTADS) protocol | Researchers | Clinical research |
Successful prenatal therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model | Xu X, Chen D, Ye X, Xia W, Xu Y, Chen Y, Shao Y, Deng J, Ding H, Liu J, Wang J, Ni H, Fu Y, Santoso S | 2021 | Blood | View Successful prenatal therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model | Researchers | Basic research |
Evaluating the Tactical Combat Casualty Care principles in civilian and military settings: systematic review, knowledge gap analysis and recommendations for future research | Strauss R, Menchetti I, Perrier L, Blondal E, Peng H, Sullivan-Kwantes W, Tien H, Nathens A, Beckett A, Callum J, da Luz LT | 2021 | Trauma Surg Acute Care Open | View Evaluating the Tactical Combat Casualty Care principles in civilian and military settings: systematic review, knowledge gap analysis and recommendations for future research | Health care providers | Clinical research |
Chapitre 15: Composants sanguins négatifs pour les anti-CMV, irradiés et lavéss | Prokopchuk-Gauk O, Solh Z | 2021 | Guide de la pratique transfusionnelle | View Chapitre 15: Composants sanguins négatifs pour les anti-CMV, irradiés et lavéss | Health care providers | Benchmarking and standard setting |
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada | Goldfarb DM, Mâsse LC, Watts AW, Hutchison SM, Muttucomaroe L, Bosman ES, Barakauskas VE, Choi A, Irvine MA, Reicherz F, Coombs D, O’Reilly C, Sediqi S, Razzaghian HR, Sadarangani M, O’Brien SF, Lavoie PM | 2021 | medRxiv | View SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada | Researchers | Clinical research |
Concentré de recherche: Transfusion de plaquettes chez les enfants atteints de cancer | Barty R | 2021 | Blood.ca website | View Concentré de recherche: Transfusion de plaquettes chez les enfants atteints de cancer | Health care providers | Benchmarking and standard setting |
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval | Grunau B, Asamoah-Boaheng M, Lavoie PM, Karim ME, Kirkham TL, Demers PA, Barakauskas V, Marquez AC, Jassem AN, O’Brien SF, Drews SJ, Haig S, Cheskes S, Goldfarb DM | 2021 | Clin Infect Dis | View A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval | Researchers | Clinical research |
Compliance with the massive hemorrhage protocol in trauma: a retrospective quality review | Khayyat H, Callum JL, Hill-Strathy M, Strauss R, Notario L, Nathens A, da Luz L | 2021 | Can J Anaesth | View Compliance with the massive hemorrhage protocol in trauma: a retrospective quality review | Health care providers | Clinical research |
Registration errors among patients receiving blood transfusions: a national analysis from 2008 to 2017 | Vijenthira S, Armali C, Downie H, Wilson A, Paton K, Berry B, Wu HX, Robitaille A, Cserti-Gazdewich C, Callum J | 2021 | Vox Sang | View Registration errors among patients receiving blood transfusions: a national analysis from 2008 to 2017 | Health care providers | Clinical research |
Concentré de recherche: Saignement pendant la chirurgie cardiaque?: le?concentré de complexe prothrombique est-il une solution de rechange au plasma? | Kron A | 2021 | Blood.ca website | View Concentré de recherche: Saignement pendant la chirurgie cardiaque?: le?concentré de complexe prothrombique est-il une solution de rechange au plasma? | Health care providers | Clinical research |
Maintaining trust in a pandemic: Blood collection agency messaging to donors and the public during the early days of COVID-19 | Haw J, Thorpe R, Holloway K | 2021 | SocArXiv | View Maintaining trust in a pandemic: Blood collection agency messaging to donors and the public during the early days of COVID-19 | Blood operators | Ethical, legal and social implications research |